| EDWARDS LIFESCIENCES |
| USA |
| Gesundheit |
| US28176E1082 / 936853 |
| EWL (Frankfurt) / EW (NYSE) |
| FRA:EWL, ETR:EWL, EWL:GR, NYSE:EW |
| S&P500 |
| https://www.edwards.com/ |
|
Edwards Lifesciences Corporation is the leading global structural heart innovation company, specializing in patient-focused medical devices for structural heart disease, critical care, and surgical monitoring. The company develops and commercializes ..
>Volltext.. |
| 40382.59 Mio. EUR |
| 37419.4 Mio. EUR |
| 5196.15 Mio. EUR |
| 1530.26 Mio. EUR |
| 907.85 Mio. EUR |
| 1.55 EUR |
| 604.09 Mio. EUR |
| 2516.46 Mio. EUR |
| 1366.09 Mio. EUR |
| 2.33 |
| -6.57% |
| 6.83% |
| - |
| - |
| - |
| EDWARDS LIFESCIENCES, EDWARDS LIFE |
| 08.04.26 |
|
||||
|
||||
|